Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
BMN-351 in Muscular Dystrophy, Duchenne: NCT07573631 Clinical Landscape Report 2026
9 min read
BMN-351 in Muscular Dystrophy, Duchenne: NCT07573631 Clinical Landscape Report 2026
11 September 2026
NCT07573631 clinical landscape for Muscular Dystrophy, Duchenne: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
UNC13A program(Trace Neuroscience) in Amyotrophic Lateral Sclerosis: NCT07674667 Clinical Landscape Report 2026
9 min read
UNC13A program(Trace Neuroscience) in Amyotrophic Lateral Sclerosis: NCT07674667 Clinical Landscape Report 2026
11 September 2026
NCT07674667 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
ORM-1153 in Refractory acute myeloid leukemia: NCT07809906 Clinical Landscape Report 2026
9 min read
ORM-1153 in Refractory acute myeloid leukemia: NCT07809906 Clinical Landscape Report 2026
11 September 2026
NCT07809906 clinical landscape for Refractory acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
Read →
Metformin Hydrochloride in Parkinson Disease: NCT07806019 Clinical Landscape Report 2026
9 min read
Metformin Hydrochloride in Parkinson Disease: NCT07806019 Clinical Landscape Report 2026
11 September 2026
NCT07806019 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mocaciclib in Triple Negative Breast Cancer: NCT07788222 Clinical Landscape Report 2026
9 min read
Mocaciclib in Triple Negative Breast Cancer: NCT07788222 Clinical Landscape Report 2026
11 September 2026
NCT07788222 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
HRS-4729 in Diabetes Mellitus, Type 2: NCT07807059 Clinical Landscape Report 2026
9 min read
HRS-4729 in Diabetes Mellitus, Type 2: NCT07807059 Clinical Landscape Report 2026
11 September 2026
NCT07807059 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
ESG-206 in Systemic Lupus Erythematosus: NCT07760155 Clinical Landscape Report 2026
9 min read
ESG-206 in Systemic Lupus Erythematosus: NCT07760155 Clinical Landscape Report 2026
11 September 2026
NCT07760155 clinical landscape for Systemic Lupus Erythematosus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mitapivat in Hemoglobin SC Disease: NCT07656415 Clinical Landscape Report 2026
9 min read
Mitapivat in Hemoglobin SC Disease: NCT07656415 Clinical Landscape Report 2026
11 September 2026
NCT07656415 clinical landscape for Hemoglobin SC Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07803653 Clinical Landscape Report 2026
9 min read
Fludarabine Phosphate in Metastatic castration-resistant prostate cancer: NCT07803653 Clinical Landscape Report 2026
11 September 2026
NCT07803653 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
DT-7012 in Locally Advanced Soft Tissue Sarcoma: NCT07802652 Clinical Landscape Report 2026
9 min read
DT-7012 in Locally Advanced Soft Tissue Sarcoma: NCT07802652 Clinical Landscape Report 2026
11 September 2026
NCT07802652 clinical landscape for Locally Advanced Soft Tissue Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
GB-0895 in Severe asthma: NCT07359846 Clinical Landscape Report 2026
9 min read
GB-0895 in Severe asthma: NCT07359846 Clinical Landscape Report 2026
11 September 2026
NCT07359846 clinical landscape for Severe asthma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Toripalimab in Renal Cell Carcinoma: NCT07744932 Clinical Landscape Report 2026
9 min read
Toripalimab in Renal Cell Carcinoma: NCT07744932 Clinical Landscape Report 2026
11 September 2026
NCT07744932 clinical landscape for Renal Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →